- Report
- September 2023
- 390 Pages
Global
From €2405EUR$2,490USD£2,058GBP
- Report
- November 2023
- 100 Pages
North America
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2023
- 100 Pages
Middle East, Africa
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2023
- 131 Pages
Europe
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- November 2023
- 132 Pages
Asia Pacific
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- April 2024
- 605 Pages
Global
From €5264EUR$5,450USD£4,504GBP
- Report
- February 2024
- 175 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- February 2024
- 200 Pages
Global
From €2405EUR$2,490USD£2,058GBP
- Report
- February 2024
- 184 Pages
Global
From €4732EUR$4,900USD£4,050GBP
- Report
- July 2023
- 188 Pages
Global
From €3076EUR$3,185USD£2,632GBP
€4394EUR$4,550USD£3,761GBP
- Report
- October 2023
- 115 Pages
Global
From €4346EUR$4,500USD£3,719GBP
- Report
- January 2024
- 200 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- November 2023
- 250 Pages
Global
From €4829EUR$5,000USD£4,132GBP
- Report
- July 2023
- 145 Pages
Global
From €4781EUR$4,950USD£4,091GBP
- Report
- June 2020
- 404 Pages
Global
From €4781EUR$4,950USD£4,091GBP
- Report
- November 2021
- 255 Pages
Global
From €2656EUR$2,750USD£2,273GBP
€5312EUR$5,500USD£4,546GBP
- Report
- May 2021
- 174 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,273GBP
- Report
- July 2022
- 100 Pages
Global
From €2656EUR$2,750USD£2,273GBP
- Report
- November 2023
- 100 Pages
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
- Report
- July 2023
- 127 Pages
Australia
From €2028EUR$2,100USD£1,736GBP
€2897EUR$3,000USD£2,479GBP
The Lung Cancer Diagnostics market is a subset of the larger Diagnostics industry. It is focused on the development and commercialization of tests and technologies that can detect and diagnose lung cancer. These tests can range from imaging techniques such as X-ray, CT scan, and MRI, to molecular tests such as gene sequencing and biomarker analysis. The goal of these tests is to detect lung cancer at an early stage, when it is most treatable.
The Lung Cancer Diagnostics market is highly competitive, with many companies offering a variety of tests and technologies. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Hologic, and Becton Dickinson. Show Less Read more